ALBIREO PHARMA, INC. Annual Return On Equity in % from 2012 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Albireo Pharma, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2021.
  • Albireo Pharma, Inc. Return On Equity for the quarter ending September 30, 2022 was -97.6 %, a 218% decline year-over-year.
  • Albireo Pharma, Inc. annual Return On Equity for 2021 was -22 %, a 69.6% increase from 2020.
  • Albireo Pharma, Inc. annual Return On Equity for 2020 was -72.3 %, a 22.2% decline from 2019.
  • Albireo Pharma, Inc. annual Return On Equity for 2019 was -59.2 %, a 82.5% decline from 2018.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -22 +50.3 +69.6% Jan 1, 2021 Dec 31, 2021
2020 -72.3 -13.1 -22.2% Jan 1, 2020 Dec 31, 2020
2019 -59.2 -26.8 -82.5% Jan 1, 2019 Dec 31, 2019
2018 -32.4 +8.13 +20.1% Jan 1, 2018 Dec 31, 2018
2017 -40.6 +12.9 +24.2% Jan 1, 2017 Dec 31, 2017
2016 -53.5 -23.2 -76.9% Jan 1, 2016 Dec 31, 2016
2015 -30.2 +26.8 +47% Jan 1, 2015 Dec 31, 2015
2014 -57.1 +8.11 +12.4% Oct 1, 2013 Sep 30, 2014
2013 -65.2 -2.14 -3.4% Oct 1, 2012 Sep 30, 2013
2012 -63 Oct 1, 2011 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.